PERINATAL OUTCOMES IN CASES WITH VARIOUS METHODS OF PREVENTION OF HYPERTENSIVE DISORDERS DURING PREGNANCY
https://doi.org/10.21508/1027-4065-2018-63-3-45-50
Abstract
The objective of this research was studying the state of newborns born to mothers with various risk factors for hypertensive disorders in dependence of the method of prevention of this pathology. The state of 130 newborns of mothers with risk factors who received various methods of preeclampsia prevention during the gestation was analyzed. In the groups of comparison, pregnancy outcomes, incidence and structure of hypertensive disorders, timing and modes of delivery, as well as the morbidity and mortality rates of newborns, depending on the method of preventive therapy of hypertensive disorders were studied. The Pearson criterion χ2 was used to evaluate the relation between qualitative characteristics. The study found that conventional prevention almost halves the development of hypertensive disorders (p <0.05), the preventive therapy with immune correction developed by us turned out to be 4 times as effective (p <0.01) vs. the pregnant women who did not receive any preventive treatment. The proposed method allows preventing severe forms of pathology and complications of pregnancy, such as intrauterine growth retardation and antenatal foetal death. The incidence of birth of premature infants decreased by a factor of 3.3 vs. the patients without treatment and by a factor of 3 vs. the pregnant women who received conventional methods of prevention. The indicators of the total morbidity of newborns decreased by a factor of 1.5 in the group with conventional treatment vs. the pregnant women without any treatment and by a factor of 3 in the group receiving prevention using the new method.
About the Author
N. A. Shakhbazova
Research Institute of Obstetrics and Gynecology of the Ministry of Health of the Republic of Azerbaijan
Azerbaijan
Azerbaijan
Baku
References
1. Suhih G.T., Hodzhaeva Z.S., Filippov O.S. Hypertensive disorders during pregnancy, during childbirth and the puerperium. Preeclampsia. Eclampsia. Clinical recommendations of the Ministry of Health of the Russian Federation. Moscow 2013; 85. (in Russ)
2. Sidorova I.S. Preeclampsia. Moscow: OOO Izdatelstvo Medical information agency, 2016; 528. (in Russ)
3. Song Clinical Praktice Guideline. Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy: Executive Summary, Canadian Hypertensive Disorders of Pregnancy Working Group, 2014; 23.
4. Shalina R.I., Sharapova O.Sh., Vyhristjuk Yu.V. Severe gestosis. Immediate results of children’s development. Vopr ginekol, akush i perinatol 2007; 4: 43–48. (in Russ)
5. Say L. Global Causes of Maternal Death: A WHO Systematic Analysis. The Lancet Global Health. 2014; 2 (6): e323-333. DOI: 10.2016/S2214109Х(14)70227-Х.
6. Kiondo P., Tumwesigye N.M., Wandabwa J., Wamuyu-Maina G., Bimenya G., Okong P. Adverse neonatal outcomes in women with pre-eclampsia in Mulago Hospital, Kampala, Uganda: a cross-sectional study. Pan African Med J 2014; 17 (1): 7. doi:10.11604/pamj.supp.2014.17.1.3014
7. Ghulmiyah L, Sibai B. Maternal mortality from preeclampsiaeclampsiа. Semin Perinatol 2012; 36 (1): 56–59. DOI: 10.1053/j.semperi.2011.09.011
8. Marret S., Ancel P.Y., Marpeau L. Neonatal and 5-year Outcomes after Birth at 30-34 Weeks of Gestation. Am J Obstet Gynecol 2007; 110 (1): 72–80. doi:10.1111/j.14710528.2006.01162.x
9. Hutcheon J.A., Lisonkova S., Joseph K.S. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 2011; 25 (4): 391–403. DOI: 10.1016/j.bpobgyn.2011.01.006
10. Churchill D., Duley L., Thornton J.G., Jones L. Interventionist versus expectant care for severe pre-eclampsia between 24 and 34 weeks’ gestation. Cochrane Database Syst Rev 2013; 7: CD003106. DOI: 10.1002/14651858.CD003106.pub2
11. National Heart Foundation of Australia. Guideline for the diagnosis and management of hypertension in adults. 2016; https://www.heartfoundation.org.au/images/uploads/publications/PRO-167_Hypertension-guideline-2016_WEB.pdf
12. Bajbarina E.N., Filippov O.S., Guseva E.V. Modernization of maternity and childhood protection in the Russian Federation: results and prospects. Akusherstvo i ginekologija 2013; 12: 4–9. (in Russ)
13. World Health Organization. Levels and trends in child mortality. Geneva, 2012; 32.
14. Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy. NICE Clinical Guidelines, No. 107. National Collaborating Centre for Womens and Childrens Health (UK). London: RCOG Press, 2010; 288.
15. Shakhbazova N.A. Clinical and immunological features of pregnancy during hypertensive conditions caused by pregnancy. Akusherstvo Ginekologiya Reproduktsiya 2014; 8 (3): 11– 17. (in Russ)
16. WHO recommendations for the prevention and treatment of preeclampsia and eclampsia. Geneva, Switzerland: Department of Maternal and Child Health, 2014; 39. (in Russ)
17. Hypertensive Disorders in Pregnancy (HDP) Guideline Summary. NY State Department of Health, 2013; 23.
18. Ushkalova E.A., Shifman E.M. The problem of unregulated use of immunoglobulin for intrauterine injection in obstetrics. Akush i gin 2011; 3: 74–80. (in Russ)
19. Cherepanov S.V., Sokolov D.I., Shljahtenko T.N. Experimental substantiation of endothelioprotective effect of immunoglobulins for intravenous administration in obstetrical pathology. Akush i ginekol 2016; 5: 82–88. (in Russ)
20. Christiansen O.B., Larsen E.C., Egerup P., Jablonowska B., Lindschou J., Gluud C. Intravenous immunoglobulin treatment for secondary recurrent miscarriage: a randomised, double-blind, placebo-controlled trial. BJOG 2015; 122 (4): 500–508. DOI: 10.1371/journal.pone.0141588
21. Wong L.F., Porter T.F., Scott J.R. Immunotherapy for recurrent miscarriage. Cochrane Database Syst. Rev. 2014; (10): CD000112. DOI: 10.1002/14651858.CD000112.pub3
Review
For citations:
Shakhbazova N.A. PERINATAL OUTCOMES IN CASES WITH VARIOUS METHODS OF PREVENTION OF HYPERTENSIVE DISORDERS DURING PREGNANCY. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2018;63(3):45-50. (In Russ.) https://doi.org/10.21508/1027-4065-2018-63-3-45-50
Views:
918
Email this article 